Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- EMA Dissatisfied with FPMAJ Policy Regarding Healthcare Reform
January 29, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
January 29, 2001
- Yoshitomiyakuhin to Increase Market Share for Antipsychotic Drugs
January 29, 2001
- Major Analysts See Matsumotokiyoshi as No. 1 Drugstore Chain Operator
January 29, 2001
- BUSINESS NEWS IN BRIEF
January 29, 2001
- NHI Program Suffers from Ordinary Loss of \119 Bil. in 1999
January 29, 2001
- Tsuruha: Full-year Sales to Total \80.9 Bil.
January 29, 2001
- Fujirebio: Net Loss due to New Retirement Allowance Accounting
January 29, 2001
- Meiji Seika to Strengthen Its Overseas Business Structures: Vice President Ogawa
January 29, 2001
- PAJ President Uehara Stresses Importance of Self-medication
January 29, 2001
- National Burden Rate Can Be Reduced 10% Through Reform: Koseisho Study Team
January 29, 2001
- JPMA Committee Calls For Deregulation to Allow Supply of Information Via Internet
January 22, 2001
- JMA to Clarify Details of Its Grand Healthcare Design
January 22, 2001
- MRs Should Take Cooperation between Medical Facilities into Account: Seminar
January 22, 2001
- Handicapped Persons to Be Given Opportunity to Become Doctors, Dentists, Nurses
January 22, 2001
- BUSINESS NEWS IN BRIEF -1-
January 22, 2001
- 2001 Meeting Schedule of the Japanese Association of Medical Sciences
January 22, 2001
- BUSINESS NEWS IN BRIEF -2-
January 22, 2001
- Celera Genomics Signs Contract with Univ. of Tokyo on Genome Database
January 22, 2001
- Daiichi Forms Alliance with MedGene
January 22, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…